Lupus Nephritis Biomarkers: A Critical Review
Top Cited Papers
Open Access
- 9 January 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (2) , 805
Abstract
Lupus nephritis (LN), a major complication in individuals diagnosed with systemic lupus erythematosus, substantially increases morbidity and mortality. Despite marked improvements in the survival of patients with severe LN over the past 50 years, complete clinical remission after immunosuppressive therapy is achieved in only half of the patients. Therefore, timely detection of LN is vital for initiating prompt therapeutic interventions and improving patient outcomes. Biomarkers have emerged as valuable tools for LN detection and monitoring; however, the complex role of these biomarkers in LN pathogenesis remains unclear. Renal biopsy remains the gold standard for the identification of the histological phenotypes of LN and guides disease management. However, the molecular pathophysiology of specific renal lesions remains poorly understood. In this review, we provide a critical, up-to-date overview of the latest developments in the field of LN biomarkers.Keywords
This publication has 216 references indexed in Scilit:
- Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritisBMC Nephrology, 2013
- Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritisArthritis Research & Therapy, 2012
- Role of MYH9 and APOL1 in African and non-African populations with lupus nephritisGenes & Immunity, 2011
- Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseasesTrends in Molecular Medicine, 2011
- Impairment of neutrophil extracellular trap degradation is associated with lupus nephritisProceedings of the National Academy of Sciences of the United States of America, 2010
- Understanding the Epidemiology and Progression of Systemic Lupus ErythematosusSeminars in Arthritis and Rheumatism, 2010
- Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohortRheumatology, 2008
- Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: Estimates obtained using hospitalization dataArthritis & Rheumatism, 2007
- A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisoloneAnnals of the Rheumatic Diseases, 2007
- A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregationBlood, 2006